Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies

Author:

Jongen Vita W.1ORCID,Reyniers Thijs2,Schim van der Loeff Maarten1345,Smekens Tom2,Hoornenborg Elske1345ORCID,van den Elshout Mark1ORCID,Zimmermann Hanne16ORCID,Coyer Liza1345ORCID,Kenyon Chris7,De Baetselier Irith7ORCID,Davidovich Udi18,de Vries Henry J. C.1459,Prins Maria1345,Laga Marie2,Vuylsteke Bea2ORCID,Boyd Anders110

Affiliation:

1. Department of Infectious Diseases Public Health Service Amsterdam Amsterdam The Netherlands

2. Department of Public Health Institute of Tropical Medicine Antwerp Belgium

3. Department of Internal Medicine University of Amsterdam Amsterdam The Netherlands

4. Amsterdam Institute for Infection and Immunity (AII) Amsterdam The Netherlands

5. Amsterdam Public Health Research Institute (APH) Amsterdam The Netherlands

6. Department of Work and Social Psychology Maastricht University Maastricht The Netherlands

7. Department of Clinical Sciences Institute of Tropical Medicine Antwerp Belgium

8. Department of Social Psychology University of Amsterdam Amsterdam The Netherlands

9. Department of Dermatology University of Amsterdam Amsterdam The Netherlands

10. Stichting HIV Monitoring Amsterdam The Netherlands

Abstract

AbstractIntroductionDaily and event‐driven oral pre‐exposure prophylaxis (PrEP) reduce the risk of HIV acquisition. PrEP use can vary over time, yet little is known about the trajectories of PrEP use irrespective of the chosen PrEP regimens among men who have sex with men (MSM).MethodsUsing data from a mobile, web‐based diary application collected daily from 17 August 2015 until 6 May 2018, we analysed PrEP use and sexual behaviour in two large cohorts, AMPrEP (Amsterdam, the Netherlands) and Be‐PrEP‐ared (Antwerp, Belgium). In both cohorts, participants could choose between daily and event‐driven oral PrEP every 3 months. We used group‐based trajectory modelling to identify trajectories of PrEP use over time and their determinants. In addition, we estimated the incidence rate of chlamydia, gonorrhoea and syphilis within these trajectories.ResultsWe included 516 MSM (n = 322 AMPrEP; n = 194 Be‐PrEP‐ared), of whom 24% chose event‐driven PrEP at PrEP initiation. Participants contributed 225,015 days of follow‐up (median = 508 days [IQR = 429−511]). Four distinct PrEP use trajectories were identified: ≤2 tablets per week (“low frequency,” 12% of the total population), 4 tablets per week (“variable,” 17%), “almost daily” (31%) and “always daily” (41%). Compared to participants with “low frequency” PrEP use, participants with “variable” (odds ratio [OR] = 2.18, 95% confidence interval [CI] = 1.04−4.60) and “almost daily” PrEP use were more often AMPrEP participants (OR = 2.64, 95% CI = 1.27−5.49). “Almost daily” PrEP users were more often employed (OR = 6.76, 95% CI = 2.10−21.75) and were younger compared to participants with “low frequency” PrEP use. In addition, the number of days on which anal sex occurred was lower among participants with “low frequency” PrEP use compared to the other groups (all p<0.001). Compared to “low frequency” PrEP users, the incidence rates of chlamydia and gonorrhoea were higher for participants with “almost daily” and “always daily” PrEP use.ConclusionsWe uncovered four distinct PrEP use trajectories, pointing to different patterns of PrEP use in practice beyond the two‐regimen dichotomy. These trajectories were related to sexual behaviour and rates of sexually transmitted infection. Tailoring PrEP care according to different PrEP use patterns could be an important strategy to improve efficient PrEP delivery.

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference24 articles.

1. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations

2. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

3. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

4. Centers for Disease Control and Prevention.Preexposure prophylaxis for the prevention of HIV infection in the United States—2021 update: a clinical practice guideline. Available at:https://www.cdc.gov/hiv/pdf/risk/prep/cdc‐hiv‐prep‐guidelines‐2021.pdf. Accessed 31 May 2022.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3